Showing 911-920 of 2927 results for "".
Epilepsy Essentials: Identifying and Treating Seizures in Autoimmune Encephalitis and Autoimmune-Associated Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/identifying-and-treating-seizures-in-autoimmune-encephalitis-and-autoimmune-associated-epilepsy/60890/Recognizing the distinctive clinical features of autoimmune-associated seizures can expedite antibody testing, guide immunotherapy decisions, and improve patient outcomes.Utility of Autoantibody Profiles
https://practicalneurology.com/diseases-diagnoses/imaging-testing/utility-of-autoantibody-profiles/31704/Algorithmic testing for autoantibody profiles is more sensitive than physician-selected single autoantibody testing.Medication-Overuse Headache
https://practicalneurology.com/diseases-diagnoses/headache-pain/medication-overuse-headache-1/31661/Successfully treating medication-overuse headache requires also treating any comorbid conditions or worsening primary headache disorder.Treating Early Relapsing Multiple Sclerosis: Induction & Escalation Approaches
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/treating-early-relapsing-multiple-sclerosis-induction-escalation-approaches/31873/Evidence-based clinical trial results are needed to guide this difficult decision-making processDementia Insights: The World Turned Upside Down:
July 2023—A Remarkable Month in the World of Alzheimer Disease Diagnosis and Treatmenthttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/dementia-insights-the-world-turned-upside-downbrjuly-2023-a-remarkable-month-in-the-world-of-alzheimer-disease-diagnosis-and-treatment/32075/A review of recent drug approvals, policy changes, and significant studies in the field.Kappa Free Light Chain Index in the Diagnosis of Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/kappa-free-light-chain-index-in-the-diagnosis-of-multiple-sclerosis/54598/Adoption of the kappa free light chain index can enhance diagnostic accuracy and reduce latency in multiple sclerosis diagnosis, complementing MRI and expert assessment in clinical decision-making.Antisense Oligonucleotide Therapies
https://practicalneurology.com/diseases-diagnoses/movement-disorders/antisense-oligonucleotide-therapies/31573/Antisense oligonucleotides are a promising new therapeutic class being studied for the treatment of movement disorders.Epilepsy Essentials: Neuromodulation for Drug-Resistant Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/epilepsy-essentials-neuromodulation-for-drug-resistant-epilepsy/31805/Neuromodulation devices provide options for individuals with drug-resistant epilepsy not suited, or not responsive, to resective treatment.The Effects of Obesity on Brain Structure and Size
https://practicalneurology.com/diseases-diagnoses/headache-pain/the-effects-of-obesity-on-brain-structure-and-size/30714/An examination of both the pathophysiology of the link between obesity and brain injury, and available strategies that may reverse it.Diagnosis and Management of Neurodegenerative Atypical Parkinsonism
https://practicalneurology.com/diseases-diagnoses/movement-disorders/diagnosis-and-management-of-neurodegenerative-atypical-parkinsonism/30455/